Astrazeneca PLC (NYSE: AZN) – Countries piling up to suspend AstraZeneca vaccine due to blood clotting problems
Oxford-AstraZeneca vaccine delayed due to fear of blood clots raises new doubts about Europe’s deployment
Following reports of blood clots, some countries are suspending the use of the AstraZeneca Covid vaccine
AstraZeneca says ‘no evidence’ of risk of blood clots through vaccination as countries suspend its use